Human Reproduction, Vol. 15, No. 7, 1457-1461,
July 2000
© 2000 European Society of Human Reproduction and Embryology
Effects of delaying puberty on bone mineralization in female rats
1 Pediatric Endocrine Unit, HaEmek Medical Center, Afula, Israel, 2 The Robert Vines Growth Research Center, The New Children's Hospital, Parramatta, NSW, Australia, 3 Department of Obstetrics and Gynecology, HaEmek Medical Central, Afula, 18101, Israel and 4 Department of Endocrinology, NV Organon, HB OssThe Netherlands
The effect of delaying puberty on bone mineralization was studied using female rats as a model. Repeated injections of gonadotrophin-releasing hormone antagonist (GnRHa) were used to suppress the onset of puberty from the age of 610 weeks. A group of control female rats was given aqueous solution injections at the same age and for the same duration. The effect of delaying puberty on bone mineralization was examined using dual energy X-ray absorptiometry (DXA) and peripheral quantitative computerized tomography (QCT), both methods being adapted for small animals. Bone mineral parameters were measured at baseline and at the ages of 10, 17 and 24 weeks in total body, femur and spine. Compared to controls, bone mineral content (BMC) and bone mineral density (BMD), as measured by DXA, were significantly decreased in GnRHa-treated rats in total body and femur at 10 and 24 weeks of age (P < 0.05). The results were even more significant after adjusting for weight. After this adjustment, spine BMC and BMD at 10, 17 and 24 weeks were significantly lower in the treatment group (P < 0.05). Trabecular BMD at the distal femur in the GnRHa treated group as measured by peripheral QCT was significantly lower (P < 0.05). However, cortical bone in the mid-femur had higher BMD, concurrent with lower cortical thickness in the treatment group. In conclusion, a delay in the onset of sexual maturation may cause prolonged, possibly irreversible defect in bone mineralization.
Key words: bone mineralization/dual energy X-ray absorpiometry/gonadotrophin-releasing-hormone hormone antagonist/peripheral quantitative computerized tomography/puberty
5 To whom correspondence should be addressed at: E-mail: ibs{at}amiad.org.il